Affiliation:
1. Molecular Biology and Biotechnology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
2. Department of Science Laboratory Technology, Faculty of Science., Lagos State University, Ojo, Lagos, Nigeria
3. Infectious Diseases Hospital, Lagos, Nigeria
Abstract
ABSTRACT
Intranasal sprays containing
Bacillus
species are being researched for treating viral respiratory tract infections. The aim of this study was to assess the relationship between the nasal carriage of
Bacillus
and COVID-19 severity. This was a cross-sectional study that collected nasopharyngeal samples from adults 18 years and above visiting two COVID-19 testing centers in Lagos, Nigeria, between September 2020 and September 2021.
Bacillus
species were cultured from the samples and confirmed using 16 s rRNA gene sequencing. The dependent variable was COVID-19 status classified as negative, asymptomatic, mild, or severe. The independent variable was the nasal carriage of
Bacillus
species. Multinomial regression analysis was done to determine the association between nasal carriage of
Bacillus
and COVID-19 severity after adjusting for age, sex, and co-morbidity status. A total of 388 participants were included in the study with mean (standard deviation) age of 40.05 (13.563) years. Sixty-one percent of the participants were male, 100 (25.8%) had severe COVID-19, 130 (33.5%) had pre-existing comorbidity, and 76 (19.6%) had
Bacillus
cultured from their nasopharyngeal specimen.
Bacillus
species presence was significantly associated with higher odds of severe COVID-19 compared to having a negative COVID-19 status (AOR = 3.347, 95% CI: 1.359, 8.243). However, the presence of
Bacillus
species was significantly associated with lower odds of severe COVID-19 compared to having a mild COVID-19 status. The study suggests that nasal carriage of
Bacillus
species is associated with the clinical course of COVID-19 and supports the exploration of
Bacillus
species in the management of viral respiratory tract infections.
IMPORTANCE
With the introduction of intranasal spray containing
Bacillus
species for the treatment of viral respiratory tract infections, such as COVID-19 and respiratory syncytial virus, identifying the association between the nasal carriage of
Bacillus
species and COVID-19 susceptibility and severity will help further substantiate the investigation of these bacteria for COVID-19 prevention and treatment. This study evaluated the association between the carriage of
Bacillus
species in the nasopharyngeal tract and COVID-19 severity and found that the presence of
Bacillus
species in the nasopharynx may significantly impact the clinical course of COVID-19.
Funder
Nigerian Institute of Medical Research
Royal Society of Tropical Medicine and Hygiene
Publisher
American Society for Microbiology